Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol - Sitbon, O; McLaughlin, V V; Badesch, D B (Thorax, 2005)
et al.